Filing Details

Accession Number:
0001437749-22-005297
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-04 16:46:21
Reporting Period:
2022-03-02
Accepted Time:
2022-03-04 16:46:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1158895 Lemaitre Vascular Inc LMAT Surgical & Medical Instruments & Apparatus (3841) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1365739 G Trent Kamke C/O Lemaitre Vascular , Inc.
63 Second Avenue
Burlington MA 01803
Senior V. P., Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-03-02 3,954 $14.13 15,439 No 4 M Direct
Common Stock Acquisiton 2022-03-02 1,633 $31.30 17,072 No 4 M Direct
Common Stock Disposition 2022-03-02 7,929 $48.22 9,143 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2022-03-02 3,954 $0.00 3,954 $14.13
Common Stock Stock Option (Right to Buy) Disposition 2022-03-02 1,633 $0.00 1,633 $31.30
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-07-25 2023-07-25 No 4 M Direct
1,774 2017-12-22 2024-12-22 No 4 M Direct
Footnotes
  1. Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
  2. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $48.00 to $48.65. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
  3. This option is fully vested and exercisable.
  4. This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vesting in equal annual installments over the remaining four years.